Andrew Tang

Cancer Institute (WIA)

Papers

1

Total Citations

42

H-Index

1

About

Andrew Tang is a leading thoracic surgeon and researcher whose work centers on advancing surgical techniques for lung cancer, with a particular focus on robotic-assisted surgery. His major contributions lie in demonstrating the oncologic equivalence of minimally invasive approaches, most notably through his highly cited 2020 study, "Robotic Approach Offers Similar Nodal Upstaging to Open Lobectomy for Clinical Stage I Non-small Cell Lung Cancer." This pivotal work, with 42 citations, provided critical evidence that robotic lobectomy achieves comparable lymph node upstaging—a key marker of accurate staging and prognosis—to traditional open surgery, challenging long-held assumptions about the limitations of minimally invasive methods. Beyond this, Tang’s research has shaped clinical guidelines by validating the safety and efficacy of robotic platforms in complex thoracic procedures, helping to expand their adoption worldwide. His impact is further underscored by his role in mentoring the next generation of surgeons and his contributions to multi-institutional trials that refine perioperative care. For students and researchers, Tang’s work exemplifies how rigorous comparative effectiveness research can bridge the gap between innovation and evidence-based practice, ultimately improving outcomes for lung cancer patients while reducing surgical trauma.

Research Focus

Key Achievements

1
H-Index
1
Papers
42
Total Citations
42
Avg Citations/Paper
🏆 Most Cited Paper
Robotic Approach Offers Similar Nodal Upstaging to Open Lobectomy for Clinical Stage I Non-small Cell Lung Cancer
42 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Cancer Institute (WIA)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago